Results 61 to 70 of about 17,756 (269)
Age‐specific melanoma risk associated with nevi: a pooled analysis from the M‐SKIP project
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.Summary Objective This study investigates the association of melanoma risk with total‐body nevus count and the presence of atypical nevi in younger (< 40 years) and older (> 60 years) individuals. Methods A pooled analysis was conducted within the M‐SKIP project, based on multiple melanoma case‐control studies.
Giulia Doi +20 more
wiley +1 more source
Regional Standardization of CLL Management: Results of a Delphi Consensus Process
European Journal of Haematology, EarlyView.ABSTRACT The therapeutic landscape of chronic lymphocytic leukemia (CLL) has been profoundly transformed by the introduction of Bruton tyrosine kinase and BCL‐2 inhibitors. Despite improved survival outcomes, treatment selection remains complex, particularly in older patients with comorbidities, frailty, and increased infectious vulnerability.
Enrica Antonia Martino +22 more
wiley +1 more source
Haemophilia, EarlyView.ABSTRACT Introduction Prophylactic factor replacement and non‐factor therapy has improved bleed prevention and clinical outcomes for people with haemophilia (PwH). The remaining burdens faced by PwH in real‐world settings, despite availability of newer therapies, are not well documented.
Víctor Jiménez Yuste +5 more
wiley +1 more source
Hematology, Transfusion and Cell Therapy, 2023 Introdução: A coleta de Células Progenitoras Hematopoéticas de Sangue Periférico (CPH-SP) é amplamente utilizada para o tratamento de pacientes acometidos por doenças hematológicas.
LK Acioli +4 more
doaj +1 more source
Transplant Infectious Disease, EarlyView.During the 2023–2024 Argentine dengue outbreak, 33 patients with hematological disease showed high complication rates, frequent hospitalization (64%), severe thrombocytopenia (90%), and 6% dengue‐attributable mortality. Transfusion‐associated cases were documented.
Gustavo Adolfo Méndez +16 more
wiley +1 more source
American Journal of Hematology, Volume 101, Issue 7, Page 1692-1705, July 2026.ABSTRACT In a large multicenter real‐world cohort, we aimed to evaluate outcomes of FLAG‐Ida salvage therapy for relapsed/refractory (R/R) acute myeloid leukemia (AML) and validated the SALFLAGE prognostic score. We analyzed 1079 adults with R/R AML treated across 112 PETHEMA institutions over 26 years (1998–2024), including patients with primary ...
Gaspar Aspas Requena +49 more
wiley +1 more source
Hematologia e histologia de tilápia do Nilo alimentada com própolis na dieta [PDF]
, 2013 Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências Agrárias, Programa de Pós-Graduação em Aquicultura, Florianópolis, 2013.A influência da suplementação com própolis na ração de tilápia do Nilo sobre os parâmetros ...
Ledic Neto, Jerko
core
, 2015 [No abstract available]3617192Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, , IARC: LyonRohr, S.S., Pelloso, L.A., Borgo, A., de Nadai, L.C ...
Melo R.A.M. +9 more
core +1 more source
Hematopoietic stem cells transplantation and acute myeloid leukemia: Brazilian guidelines [PDF]
, 2010 O objetivo deste trabalho foi definir diretrizes para a indicação do transplante de células-tronco hematopoéticas (TCTH) no tratamento da leucemia mieloide aguda (LMA) no Brasil.
Adriano M. Arantes +20 more
core +1 more source
HemaSphere, Volume 10, Issue 6, June 2026.Abstract Neurodegenerative Langerhans cell histiocytosis (ND‐LCH) is a severe and debilitating complication of LCH with no effective treatment. In this study, we assessed the efficacy of MAPK inhibitors (MAPKi) in a large cohort of children with ND‐LCH. We included pediatric patients with ND‐LCH who received MAPKi between 2013 and 2025.
Francesco Pegoraro +38 more
wiley +1 more source